Login
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc

neurocrine.com

Neurocrine Biosciences (NASDAQ: NBIX) is a biopharmaceutical company that develops and commercializes medicines for neurological and endocrine-related diseases. The filing excerpts provided do not contain sufficient detail to describe specific revenue figures, product names, segment breakdowns, market position, or other business specifics for FY2025. The 10-K was filed on 2026-02-11 under accession number 000091447526000007, but the substantive business, financial, and product content from the filing was not included in the excerpts made available for this summary. A complete description will require access to the full Item 1 Business section and financial statements from that filing.

Financial Snapshot

Revenue
TTM
$3.102B
Gross Margin
TTM
98.18%
Net Income
TTM
$668.6M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
292.91%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$3.407B
Cash
2026 Q1
P/E
TTM
26.18
Free Cash Flow
TTM
$831.3M

Stock Price

Loading...
Market Cap: $17.506 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support